TransTech Pharma is a clinical-stage
pharmaceutical company focused on the
discovery, development, and commercialization
of small molecule and protein therapeutics to fill
unmet medical needs.
TransTech Pharma, Inc. Obtains Exclusive License to Glucokinase Activator Program for the treatment of Diabetes from Novo Nordisk
     
 

HOME • TERMS OF USE • SITEMAP • CAREERS • CONTACT US

© Copyright 2005,Transtech Pharma, Inc., all rights reserved. ® Marks owned by TransTech Pharma, Inc.
Built @ Beyond Email, Inc.